Study of how Charcot-Marie-Tooth (CMT) develops over time
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without nerve disease. The goal is to better understand different CMT types and how symptoms and nerve test results change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can come to a study center in person for the first visit
- You have CMT with a known (or strongly suspected) genetic cause, or a close relative with a matching CMT gene change
- If the gene result is unclear, the study must be able to classify it using set rules (or your family pattern fits those rules)
- You (or your parent/guardian/authorized helper) can understand and sign the consent forms; ages 13–17 may need an assent form too
- For a study control person: you should not have peripheral (nerve) neuropathy, based on the investigator
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Charcot-Marie-Tooth disease (CMT) or related inherited nerve conditions change over time. It may help researchers better understand what to expect and guide future treatments.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without it. It aims to better understand CMT, using both clinical symptoms and genetic test results, which may help future care.
This study examines tremor (involuntary shaking) in people with Charcot-Marie-Tooth disease, a genetic nerve condition that affects the legs and feet. Researchers will compare people with CMT who have tremor to healthy volunteers to better understand this symptom.
This study collects blood, saliva, or skin samples from people with Charcot-Marie-Tooth disease (CMT) and healthy volunteers. The samples are used to create stem cells (iPSCs) and build a biobank to help researchers understand and treat CMT.
This study watches how people with certain muscle or nerve diseases walk over time. It may help doctors understand changes in walking patterns and is open to adults who can walk and have a genetic diagnosis of a neuromuscular condition.
This study looks at DNA changes in families with Charcot-Marie-Tooth (CMT), especially a known gene duplication called PMP22. It aims to understand what other genetic factors may change how CMT shows up, which could help future diagnosis and care.
Hear when a new Charcot-Marie-Tooth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.